Intravenous cocaine discrimination in humans

Experimental and Clinical Psychopharmacology

Volumn 14, Issue 2, 2006, Pages 99-108

  Johanson, Chris Ellyn ^a   Lundahl, Leslie H ^a   Lockhart, Nancy ^a   Schubiner, Howard ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PROVIDENCE HOSPITAL   (United States)

Author keywords

Cocaine; Drug discrimination; Humans; Intravenous

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS; COCAINE; METHAMPHETAMINE; OPIATE DERIVATIVE; PENTOBARBITAL; PSYCHEDELIC AGENT; SEDATIVE AGENT; SODIUM CHLORIDE;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RATING SCALE; SEDATION; SENSITIVITY AND SPECIFICITY; TOBACCO; VISUAL ANALOG SCALE;

BLOOD PRESSURE; COCAINE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHAMPHETAMINE;

EID: 33745606711     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.14.2.99     Document Type: Article

References (27)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Chilcoat, H., & Johanson, C. (1998). Vulnerability to cocaine abuse. In S. Higgins & J. Katz (Eds.), Cocaine abuse research: Pharmacology, behavior, and clinical application (pp. 313-334). San Diego, CA: Academic Press.
3. Epstein, D. H., Silverman, K., Henningfield, J. E., & Preston, K. L. (1999). Low-dose oral cocaine in humans: Acquisition of discrimination and time-course of effects. Behavioural Pharmacology, 10, 531-542.
4. Garza, R. D., & Johanson, C. E. (1983). The discriminative stimulus properties of cocaine in the rhesus monkey. Pharmacology Biochemistry and Behavior, 19, 145-148.
5. Haertzen, C. A. (1966). Development of scales based on patterns of drug effects using the Addiction Research Center Inventory (ARCI). Psychological Reports, 18, 163-194.
6. Haney, M., Hart, C., Collins, E. D., & Foltin, R. W. (2005). Smoked cocaine discrimination in humans: Effects of gabapentin. Drug and Alcohol Dependence, 80, 53-61.
7. Johanson, C. (1991). Discriminative stimulus effects of psychomotor stimulants and benzodiazepines in humans. In R. Glennon, T. Jarbe, & J. Frankenheim (Eds.), Drug discrimination: Applications to drug abuse research (Vol. 116, pp. 181-196). Rockville, MD: National Institute on Drug Abuse.
8. Johanson, C. E. (1992). The use of human drug discrimination studies in medication development. NIDA Research Monograph, 119, 180-184.
9. Johanson, C., Schuh, K., & Schubiner, H. (2000). Discrimination of intravenous cocaine in humans. Drug and Alcohol Dependence, 60(Suppl. 1), S101.
10. Kelly, T. H., Stoops, W. W., Perry, A. S., Prendergast, M. A., & Rush, C. R. (2003). Clinical neuropharmacology of drugs of abuse: A comparison of drug-discrimination and subject-report measures. Behavioral Cognitive Neuroscience Review, 2, 227-260.
11. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective and behavioral effects of amphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
12. Negus, S. S., Mello, N. K., & Fivel, P. A. (2000). Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology (Berlin), 152, 398-407.
13. Oliveto, A. H., McCance-Katz, E., Singha, A., Hameedi, F., & Kosten, T. R. (1998). Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behavioural Pharmacology, 9, 207-217.
14. Oliveto, A. H., Rosen, M. I., Woods, S. W., & Kosten, T. R. (1995). Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. Journal of Pharmacology and Experimental Therapeutics, 272, 231-241.
15. Perkins, K. A., DiMarco, A., Grobe, J. E., Scierka, A., & Stiller, R. L. (1994). Nicotine discrimination in male and female smokers. Psychopharmacology (Berlin), 116, 407-413.
16. Preston, K. L., & Bigelow, G. E. (1994). Drug discrimination assessment of agonist-antagonist opioids in humans: A three-choice saline-hydromorphone-butorphanol procedure. Journal of Pharmacology and Experimental Therapeutics, 271, 48-60.
17. Rush, C. R., & Baker, R. W. (2001). Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Experimental and Clinical Psychopharmacology, 9, 59-73.
18. Rush, C. R., Critchfield, T. S., Troisi, J. R., & Griffiths, R. R. (1995). Discriminative stimulus effects of diazepam and buspirone in normal volunteers. Journal of the Experimental Analysis of Behavior, 63, 277-294.
19. Samele, C., Shine, P. J., & Stolerman, I. P. (1991). A bibliography of drug discrimination research, 1989-1991. Behavioural Pharmacology, 3, 171-192.
20. Schuh, K. J., Schubiner, H., & Johanson, C. E. (2000). Discrimination of intranasal cocaine. Behavioural Pharmacology, 11, 511-515.
21. Schuster, C., Fischman, M., & Johanson, C. (1981). Internal stimulus control and subjective effects of drugs. In T. Thompson & C. Johanson (Eds.), Behavioral pharmacology of human drug dependence, 37 (pp. 116-129). Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services.
22. Smith, B. J., & Bickel, W. K. (1999). Flumazenil discrimination by humans under a two-response and a novel-response procedure. Journal of Pharmacology and Experimental Therapeutics, 291, 1257-1268.
23. Stolerman, I. P., Rasul, F., & Shine, P. J. (1989). Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987. Psychopharmacology (Berlin), 98, 1-19.
24. Stolerman, I. P., Samele, C., Kamien, J. B., Mariathasan, E. A., & Hague, D. S. (1995). A bibliography of drug discrimination research, 1992-1994. Behavioural Pharmacology, 6, 643-668.
25. Stolerman, I. P., & Shine, P. J. (1985). Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983. Psychopharmacology (Berlin), 86, 1-11.
26. Tiffany, S. T., Singleton, E., Haertzen, C. A., & Henningfield, J. E. (1993). The development of a cocaine craving questionnaire. Drug and Alcohol Dependence, 34, 19-28.
27. Vocci, F. J., Acri, J., & Elkashef, A. (2005). Medication development for addictive disorders: The state of the science. American Journal of Psychiatry, 162, 1432-1440.